BridgeBio files for $225M initial public offering
The company, which builds subsidiary companies centered around genetically driven diseases, said it would trade on the Nasdaq under the ticker symbol BBIO.
Eidos Theraputics
The company, which builds subsidiary companies centered around genetically driven diseases, said it would trade on the Nasdaq under the ticker symbol BBIO.